Multicomponent Intervention Study- Blood Donors With High Cholesterol
Recruiting · NCT05693701 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Texas Southwestern Medical Center
View the official record on ClinicalTrials.gov →Interventions studied
Implementation Strategy BundleUsual care notification
What this trial is about
The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).
Who can take part
Age range
18 Years to 75 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Blood donors from Carter BloodCare with high cholesterol meeting MEDPED FH criteria
- Age 18 to 75 years
Exclusion criteria
- Currently taking medication to lower cholesterol
- Taking any medication that can interact with statins
- Pregnancy
- Identified secondary cause of elevated lipids
- Chronic liver disease or significantly elevated liver function tests (\> 3 times upper limit)
Where it is running
1 location listed across 1 US state.
- UT Southwestern Medical Center - Dallas, Texas, United States